ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Qiagen NV

Qiagen NV (QIA)

41.095
0.725
(1.80%)
Closed November 24 4:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
41.095
Bid
40.92
Ask
41.265
Volume
6,763
40.36 Day's Range 41.195
0.00 52 Week Range 0.00
Market Cap
Previous Close
40.37
Open
40.36
Last Trade
12
@
41.195
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
228,202,755
Dividend Yield
-
PE Ratio
20.13
Earnings Per Share (EPS)
2.12
Revenue
1.97B
Net Profit
484.81M

About Qiagen NV

Sector
Biological Pds,ex Diagnstics
Industry
Biogenetic (human)
Website
Headquarters
Venlo, Limburg, Nld
Founded
1984
Qiagen NV is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker QIA. The last closing price for Qiagen NV was 40.37 €. Over the last year, Qiagen NV shares have traded in a share price range of 0.00 € to 0.00 €.

Qiagen NV currently has 228,202,755 shares outstanding. The market capitalization of Qiagen NV is 9.21 € billion. Qiagen NV has a price to earnings ratio (PE ratio) of 20.13.

QIA Latest News

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA-approved...

Neue Partnerschaft zwischen QIAGEN und Penn State University treibt Mikrobiomwissenschaften voran

Neue Partnerschaft zwischen QIAGEN und Penn State University treibt Mikrobiomwissenschaften voran Partnerschaft gestaltet Forschung, Bildung und Informationsarbeit auf dem Fachgebiet der...

QIAGEN gibt Details zum Abschluss des synthetischen Aktienrückkaufs über bis zu rund $300 Mio. bekannt

QIAGEN gibt Details zum Abschluss des synthetischen Aktienrückkaufs über bis zu rund $300 Mio. bekannt VENLO, Niederlande, Jan. 18, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN;...

QIAGEN gibt Pläne zur Rückzahlung von rund $300 Mio. an Aktionärinnen und Aktionäre bekannt

QIAGEN gibt Pläne zur Rückzahlung von rund $300 Mio. an Aktionärinnen und Aktionäre bekannt Kapitalrückzahlung durch synthetischen Aktienrückkauf // Rückzahlung von bis zu $300 Mio. – von...

QIAGEN verstärkt Investitionen in sein Bioinformatik-Geschäft QIAGEN Digital Insights

QIAGEN verstärkt Investitionen in sein Bioinformatik-Geschäft QIAGEN Digital Insights Investitionen in QIAGEN Digital Insights (QDI) stärken führende Branchenposition durch profitable...

QIAGEN expandiert im Nahen Osten mit neuer regionaler Zentrale und Großprojekten

QIAGEN expandiert im Nahen Osten mit neuer regionaler Zentrale und Großprojekten QIAGEN eröffnet Anfang 2024 neue regionale Zentrale in Riad, Saudi-Arabien, um wachsende Präsenz vor Ort zu...

DNA Labs International löst mit QIAGEN Workflow für forensische genetische Genealogie bedeutende „Cold Cases“

DNA Labs International löst mit QIAGEN Workflow für forensische genetische Genealogie bedeutende „Cold Cases“ DNA Labs International löst in den USA mithilfe von ForenSeq Kintelligence von...

QIAGEN bringt TissueLyser III und RNeasy PowerMax Soil Pro Kit für verbesserte Probenverarbeitung und RNA-Isolierung auf den Markt

QIAGEN bringt TissueLyser III und RNeasy PowerMax Soil Pro Kit für verbesserte Probenverarbeitung und RNA-Isolierung auf den Markt TissueLyser III schließt Proben wie Knochen, tierisches und...

Erweitertes Portfolio für Biopharma und Lebensmittelsicherheit: QIAGEN bringt neue digitale PCR-Kits und aktualisierte Software für QIAcuity auf den Markt

Erweitertes Portfolio für Biopharma und Lebensmittelsicherheit: QIAGEN bringt neue digitale PCR-Kits und aktualisierte Software für QIAcuity auf den Markt Drei neue QIAcuity-Kits erweitern...

QIAGEN bringt kompletten „Sample to Insight“-Workflow für die Mikrobiomforschung auf den Markt

QIAGEN bringt kompletten „Sample to Insight“-Workflow für die Mikrobiomforschung auf den Markt Vereinfachter und schnellerer Workflow mit hochqualitativen DNA-Extraktionskits...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
988Eat & Beyond Global Holdings Inc
0.11 €
(83.33%)
90.79k
7M0ASpectra7 Microsystems Inc
0.14 €
(77.22%)
4.2k
TR9OTRS AG
17.10 €
(71.86%)
85.37k
RQ0DWave Quantum Inc
2.764 €
(46.63%)
2.02M
CFCaconnic AG
1.30 €
(46.07%)
129.74k
7S2Scotch Creek Ventures Inc
0.003 €
(-65.12%)
200
9HBKomo Plant Based Foods Inc
0.005 €
(-58.33%)
200
NL8Genesis Ai Corp
0.0058 €
(-52.46%)
19.55k
0PV2Moovly Media Inc
0.005 €
(-44.44%)
29.5k
BVU3St James Gold Corp
0.07 €
(-34.58%)
500
D7GNel ASA
0.2589 €
(3.15%)
6.92M
P1MPeninsula Energy Limited
0.0368 €
(2.22%)
3.23M
BT81PowerHouse Energy Group Plc
0.0126 €
(5.00%)
2.09M
RQ0DWave Quantum Inc
2.764 €
(46.63%)
2.02M
GHUADX Energy Ltd
0.032 €
(-1.84%)
1.58M

Discussion

View Full Feed
tdbowieknife tdbowieknife 2 minutes ago
Alot of tweeting that says nothing about what the product is...

Lol...

Can you just tell the board what Baron Capital is selling, or the service that it provides?


..


Buyer Beware
Pump and dump
http://images
BCAP
BigBang BigBang 3 minutes ago
And, rest assured, I will never ask you a question again.
COOP
CaptHowdy CaptHowdy 4 minutes ago
3 more weeks of this nonsense trading under $1 and Fernandez gets a gift wrapped delisting notice from NASDAQ compliance department for Christmas.

RXMD would have been much better off uplisting on their own merits and simply continued paying down the FIFE convertible note. Bringing o
NXPL
Checkmate 36 Checkmate 36 4 minutes ago
Wait……so you are telling me that you have me on ignore, and you can’t ignore me?

Goes to show how feeble minded one can be.

Hush now, it’s past your bed time, go night night. You will have all day tomorrow to tell us how bad of a decision you made in investing in this
NWBO
gitreal gitreal 5 minutes ago
Aabb owns etzatlan plant

Prove it.
AABB
rbtree rbtree 5 minutes ago
The 5 year chart doesn't lie. It is, however, pathetic. Dont buy garbage wannabe OTC mining companies.
BMXI
excel excel 6 minutes ago
Nothing like handing the Rams field position for a score. Why the REF who had the best view didn't go to the REF who threw the flag and say ................... no ............... no way that was PI I don't know. The good old boys REF team right there. NFL you can market all you want but if that wasn
jdcpa1 jdcpa1 8 minutes ago
Acquisition accounting. Most one arm quarterback will never understand it. Totally cool that you are lost in space like Kam..  lol
SPZI
dinogreeves dinogreeves 9 minutes ago
Anyone remember this from somewhere?

https://investorshub.advfn.com/uimage/uploads/2024/11/24/kkuybScreen_Shot_2024-10-30_at_1.37.11_PM.webp
SMCI
WithEyesOpen WithEyesOpen 9 minutes ago
Waiting...waiting... waiting
NBRI
dinogreeves dinogreeves 11 minutes ago
We will be in love again, when Delfin brings it home

https://www.youtube.com/watch?v=w6w0cy_1HY4
TGLO
GolfnutBoston GolfnutBoston 16 minutes ago
Hi Risk, perhaps Jim has all these NDA's, Non Disclosure Agreements in effect and his hands are tied. ;-) 
AFFU
dreamhouse33 dreamhouse33 17 minutes ago
Is there dial-in information for tomorrow available?
NSAV
Hardazoak Hardazoak 17 minutes ago
Benny says gold is getting choppered out every so often. Plant will be high security. Does not show now but will be state of the art high tech security.
AABB
hookrider hookrider 18 minutes ago
rooster: No, son it's because Trump is not in office and can't pardon anyone yet!!!!
gfp927z gfp927z 18 minutes ago
>>> Concerns About Credit Risk in SRTs Are Growing


Bloomberg

by Neil Callanan, Laura Noonan, Tasos Vossos and Nina Trentmann

November 16, 2024


https://finance.yahoo.com/news/concerns-credit-risk-srts-growing-200000839.html
leverage102 leverage102 18 minutes ago
OK Major, if you have nothing of substance, I'll Proof read next time. I Countered the Firms MISINFORMATION, Did I Shake you ? I'll Post it following thissss Post; lol
NSAV
Jackxkr Jackxkr 19 minutes ago
What drug?
NWBO
ignatiusrielly35 ignatiusrielly35 19 minutes ago
Whether SAVA's results are good or bad, they will not effect AVXL as you suggest, either way. 
AVXL
JJ8 JJ8 19 minutes ago
Dell share price had a Double Top Breakout on 21-Nov-2024.GLTA
DELL
janice shell janice shell 20 minutes ago
I know what you mean.
dstock07734 dstock07734 20 minutes ago
You are welcome.

Guess what kind of drug can be used to treat GVHD. It is CSF1R-I!
NWBO